Tag Archives: underwritten

Big time losers and the reasons why (CVC, ITMN, MELA)

Posted on December 16, 2011 by Josie Middleton

In this report: Cablevision Systems (NYSE:CVC), InterMune (NASDAQ:ITMN) and MELA Sciences (NASDAQ:MELA).

Cablevision Systems (NYSE:CVC) is trading over 14 percent lower today after the company’s COO Tom Rutledge has resigned. Analysts have speculated that the resignation could indicate that the …

Posted in Latest Headlines, Reports | Tagged advisory, Analysts, business, Cablevision Systems, common stock, company, COO, corporate, CVC, drug, FDA, InterMune, IQWIG, ITMN, launch, MELA, Mela Sciences, MelaFind, NASDAQ, NASDAQ:ITMN, NASDAQ:MELA, net proceeds, NYSE, NYSE:CVC, public offering, report, resignation, sell, shares, speculated, Tom Rutledge, trades, trading, underwritten | Comments Off

Big time losers and the reasons why (MVIS, ALIM, BRIL)

Posted on November 11, 2011 by Josie Middleton

In this report: Alimera Sciences (NASDAQ:ALIM), Bio-Reference Laboratories Inc. (NASDAQ:BRIL) and Microvision Inc. (NASDAQ:MVIS)

Alimera Sciences (NASDAQ:ALIM) has tumbled by more than 72 percent today after the company announce that it received a complete response letter from the FDA regarding …

Posted in Latest Headlines, Reports, Top Post | Tagged ALIM, Alimera Sciences, approve, Bio-Reference Laboratories Inc., BRIL, buyback, common shares, company, FDA, Iluvien, market, Microvision Inc., MVIS, NASDAQ, NASDAQ:ALIM, NASDAQ:BRIL, NASDAQ:MVIS, new drug application, proceeds, public offering, shareholders, stock, stock repurchase program, undervalued, underwriter, underwritten, warrants | Comments Off

What the fuss WMS Industries, Opexa Therapeutics and Hornbeck Offsore?

Posted on November 8, 2011 by Josie Middleton

In this report: WMS Industries (NYSE:WMS), Opexa Therapeutics (NYSE:OPXA) and Hornbeck Offshore (NYSE:HOS).

WMS Industries (NYSE:WMS) is trading over 12 percent lower today after the slot machine maker reported weaker than expected results for its first quarter. The company earned …

Posted in Latest Headlines, Reports | Tagged acquisitions, candidate, common stockm funds, company, decision, drug, earned, expected, Fast Track, FDA, Hornbeck Offshore, HOS, NYSE, NYSE:HOS, NYSE:OPXA, NYSE:WMS, Opexa Therapeutics, OPXA, patients, predictions, public offering, quarter, results, revenue, review, Secondary Progressive Multiple Sclerosis, slot machinie, Tovaxin, trading, underwritten, vessel construction, Wall Street, WMS, WMS Industries | Comments Off

Motives behind the motion (ETRM, MKC, CBK)

Posted on September 23, 2011 by Martin Timble

In this report: EnteroMedics Inc. (NASDAQ:ETRM), Christopher & Banks Corp. (NYSE:CBK) and McCormick & Company (NYSE:MKC).

EnteroMedics Inc. (NASDAQ:ETRM) is trading more than 12.3 percent lower today after the company announced on Friday that its has priced an underwritten public …

Posted in Latest Headlines, Reports | Tagged Analysts, apparel, Buy, capital, CBK, Christopher & Banks Corp, common stock, company, coverage, EnteroMedics Inc, estimated, ETRM, firm, forecasted, growth, initiated, Kebanc Capital, loss, Maestro RC Systems, margins, McCormick & Company, MKC, NASDAQ:ETRM, net loss, NYSE:CBK, NYSE:MKC, prediction, price, price target, products, public offering, quarter, rating, reguatory, report, retailer, revenue, sale, shares, specialty food maker, trading, traes, underwritten, Wall Street, warrants | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.